TITLE

Germany : Bayer continues positive business development

PUB. DATE
July 2014
SOURCE
TendersInfo News;7/31/2014, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that pharmaceutical company Bayer Group has reported the rise in revenue and profit as of second quarter of 2014 and considered as a good business development. It mentions that EBITDA before special items and core earnings per share also showed improvement and the planned acquisition of the consumer care activities of U.S. company Merck. It presents the views of Marijn Dekkers, Management Board Chairman, of Bayer, on the same.
ACCESSION #
116733646

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics